Glasgow Outcome Scale — Extended (GOSE)
Eight-point outcome measure for traumatic brain injury (Wilson 1998), used as primary endpoint in TBI trials and clinics. Assessed via structured interview.
Score interpretation
→ End-of-life or chronic disorders of consciousness pathway (RCP 2020). Specialist neurorehabilitation MDT, advance care planning, family support.
→ Specialist inpatient neurorehabilitation; long-term care planning; carer support; spasticity, seizure and bladder management.
→ Community neurorehabilitation; vocational rehabilitation; cognitive therapy; review of fitness to drive (DVLA).
→ Outpatient follow-up; address residual symptoms (post-concussive headache, sleep, mood). Reassure and re-integrate.
Interpretation bands for the GOSE. Apply clinical judgement and local guidance.
References
Related
Curated clinical cross-links plus same-class fallbacks.
- Cetuximab · Anti-EGFR Monoclonal Antibody — Head and Neck Cancer
- Cisplatin · Platinum Chemotherapy — Head and Neck Cancer
- Methotrexate · Chemotherapy / Immunosuppressant — Head and Neck / Granulomatosis
- Pembrolizumab (Head and Neck SCC) · PD-1 Inhibitor
- Nivolumab (Head and Neck SCC) · PD-1 Inhibitor
- Naltrexone · Opioid Receptor Antagonist
- Acute Stroke / TIA Assessment · NICE NG128; RCP Stroke Guidelines 2023
- Status Epilepticus (Adults) · NICE CG137; ESEM guidelines; RCP Neurology Guidelines
- Suspected Subarachnoid Haemorrhage · NICE NG228; RCEM 2023; AHA/ASA 2023
- Adult Head Injury · NICE NG232 (2023)
- Bell's Palsy / Facial Nerve Palsy · ENT UK 2017; AAN
- Vertigo Workup · ENT UK; NICE CKS
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.